Suzanne Coberly

Senior Director, Translational Pathology

Role
Senior Director, Translational Pathology at Bristol Myers Squibb
Location
San Mateo, CA, US
LinkedIn followers
500 followers
Healthcare & Human ServicesView LinkedIn profile

About Suzanne Coberly

Translational Pathology Director, strategic leader, and creative physician-scientist with eighteen years of experience developing innovative small laboratory groups and directing translational pathology research on target validation, investigative toxicology and mechanism of action of therapeutics with the aim of delineating appropriate patient populations and safety issues. Passionate about translating this research into tissue based & molecular clinical biomarkers & companion diagnostics. Experienced in drug development and companion diagnostic/IVD process from research through development, commercialization and beyond. Expert in anatomic pathology and clinical molecular genetics. Successful liaison and negotiator with FDA, academic, and business collaborators. Effective functional manager of employees and consultants in both pathology and diagnostic development. Excellent communications and interpersonal skills. Organized, thorough, high energy, results oriented. Known for taking scientific discoveries and converting them to marketable reality.

Experience

  1. Senior Director, Translational Pathology

    Bristol Myers Squibb

    Nov 2021 — Present · San Francisco, CA, US

    Senior director and founder of discovery/translational pathology lab supporting Oncology Thematic Research Centers in Oncology (Oncogenesis & Immuno-oncology/CAR-T). Our translational pathology lab is being established in San Diego and will provide pathobiology and technical pathology support. It\'s capabilities include basic histopathology, novel tissue based assay development (IHC/ISH/multiplex), image analysis & other cutting edge pathology technologies, expert pathologist support, and scientific pathobiology consultation. We are working with the Oncogenesis & IOCT teams to advance novel drugs from early stage target validation through clinical proof of concept (Ph1/2) by providing expert pathobiology scientific support, high quality biomarker research, and the production of prototype pathology assays for clinical usage (MOA or PD biomarker and prototype patient selection).

Education

  • University of California, Davis - School of Medicine

    MD, Medicine

    1986 — 1991

  • UC Davis

    MA, Genetics

    1984 — 1991

Skills

  • Laboratory Skills
  • Clinical Research
  • Laboratory
  • Drug Development
  • Biopharmaceuticals
  • Hematology
  • Assay Development
  • Pharmaceutical Industry
  • Genomics
  • Molecular Biology
  • In Vivo
  • Infectious Diseases
  • Clinical Trials
  • Translational Research
  • Immunohistochemistry
  • Cancer Research
  • Translational Medicine
  • Molecular Genetics
  • Validation
  • Lifesciences
  • Anatomic Pathology
  • Medical Diagnostics
  • Clinical Molecular Genetics
  • Clinical Development
  • Drug Discovery
  • Life Sciences

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Suzanne Coberly — Email, Phone Number & Contact Info | Unifers